According to OPKO Health
's latest financial reports the company has $1.38 B in net assets.
A companyโs net assets is the sum of its assets minus the sum of its liabilities.
Year | Net assets | Change |
---|---|---|
2023-12-31 | $1.38 B | -11.04% |
2022-12-31 | $1.56 B | -7.33% |
2021-12-31 | $1.68 B | 0.81% |
2020-12-31 | $1.67 B | 3.52% |
2019-12-31 | $1.61 B | -9.86% |
2018-12-31 | $1.79 B | -2.84% |
2017-12-31 | $1.84 B | -11.86% |
2016-12-31 | $2.09 B | 5.66% |
2015-12-31 | $1.97 B | 136.89% |
2014-12-31 | $0.83 B | -4.27% |
2013-12-31 | $0.87 B | 329.45% |
2012-12-31 | $0.20 B | 9.72% |
2011-12-31 | $0.18 B | 703.7% |
2010-12-31 | $23.05 M | -27.05% |
2009-12-31 | $31.59 M | 8701.95% |
2008-12-31 | $0.35 M | -97.86% |
2007-12-31 | $16.78 M | 79823.81% |
2006-12-31 | $0.02 M | -99.76% |
2005-12-31 | $8.72 M | -11.27% |
2004-12-31 | $9.83 M | -4.59% |
2003-12-31 | $10.3 M | -35.9% |
2002-12-31 | $16.07 M | -38.46% |
2001-12-31 | $26.12 M |
Company | Net assets | differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $68.77 B | 4,850.55% | ๐บ๐ธ USA |
Abbott Laboratories ABT | $38.82 B | 2,694.88% | ๐บ๐ธ USA |
Regeneron Pharmaceuticals REGN | $25.97 B | 1,769.62% | ๐บ๐ธ USA |
Bristol-Myers Squibb BMY | $29.48 B | 2,022.41% | ๐บ๐ธ USA |
LabCorp LH | $7.89 B | 467.98% | ๐บ๐ธ USA |
Alnylam Pharmaceuticals
ALNY | -$0.23 B | -115.88% | ๐บ๐ธ USA |
Teva Pharmaceutical Industries TEVA | $8.12 B | 484.93% | ๐ฎ๐ฑ Israel |
Ardelyx ARDX | $0.16 B | -87.99% | ๐บ๐ธ USA |